Ineffective therapies for rheumatoid arthritis cost patients more than $2 billion a year, according to a paper in Arthritis and Rheumatology.
That could be changing as scientists use genetic profiling of joint tissue to see which drugs will work for patients, according to a new Northwestern Medicine study.
Instead of a trial and error approach to treating RA, scientists hope to develop genetic profiles to show them which medicines will be most effective.
Allyson Good curates senior living, health, and family content. She is formerly the Managing Editor of Active Life, a print newspaper published in 2016-2017 for seniors, choosing practical articles on health, money, safety, and everyday living for older readers. She is also an avid gardener and offers up Garden Hints and Tips on a regular basis.
